Elad Sharon

Hebrew University of Jerusalem - Department of Developmental Biology and Cancer Research

Jerusalem

Israel

SCHOLARLY PAPERS

2

DOWNLOADS

147

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (2)

1.

Efficacy and Safety of Vedolizumab and Infliximab Treatment for Immune-Mediated Diarrhea and Colitis in Cancer Patients: A Multi-Center Study

Number of pages: 24 Posted: 02 Mar 2021
Central South University - Department of Oncology, Memorial Sloan Kettering Cancer Center, MD Anderson Cancer Center - Department of Gastroenterology, Hepatology and Nutrition, Memorial Sloan Kettering Cancer Center - Gastroenterology, Hepatology & Nutrition Service, Memorial Sloan Kettering Cancer Center, University of Texas at Houston - Department of Biostatistics, Johns Hopkins University, National Cancer Institute - Division of Cancer Treatment and Diagnosis, University of Texas at Houston - Department of Melanoma Medical Oncology, Northwestern University, University of Texas at Houston - Department of Melanoma Medical Oncology, Centre Hospitalier Universitaire Vaudois - Service Immunologie Et Allergie, University of Texas at Houston - Department of Genitourinary Medical Oncology, MD Anderson Cancer Center - Department of Gastroenterology, Hepatology and Nutrition, Hebrew University of Jerusalem - Department of Developmental Biology and Cancer Research, Memorial Sloan Kettering Cancer Center - Ludwig Collaborative and Swim Across America Laboratory, University of Washington and MD Anderson Cancer Center - Department of Gastroenterology, Hepatology and Nutrition
Downloads 97 (374,770)

Abstract:

Loading...

2.

ACE2 Co-Evolutionary Pattern Suggests Targets for Pharmaceutical Intervention in the COVID-19 Pandemic

Number of pages: 7 Posted: 21 Apr 2020
Hebrew University of Jerusalem - Department of Developmental Biology and Cancer Research, Hebrew University of Jerusalem - Department of Developmental Biology and Cancer Research, Hebrew University of Jerusalem - Department of Developmental Biology and Cancer Research, Hebrew University of Jerusalem - Department of Developmental Biology and Cancer Research, Hebrew University of Jerusalem - Department of Developmental Biology and Cancer Research, Hebrew University of Jerusalem - Department of Clinical Microbiology and Infectious Diseases and Hebrew University of Jerusalem - Department of Developmental Biology and Cancer Research
Downloads 50 (532,175)

Abstract:

Loading...

COVID-19, SARS-CoV-2, Phylogenetic profiling, evolution, ACE2, NSAIDs